TAVI: current and future perspectives for adjunctive pharmacological therapy
Chairperson: Stephan WINDECKER
Objectives:
To understand TAVI: patient population characteristics, approved devices and expected clinical outcomesTo evaluate current and future antithrombotic therapy options around TAVI
To understand future perspectives and upcoming studies
Lectures
Session objectives
S. Windecker
TAVI: a paradigm shift in the treatment of symptomatic, severe aortic stenosis - Past, present and future
M.B. Leon
TAVI-2015: stroke and bleeding risk update
A.S. Petronio
Solved and unsolved issues of antithrombotic therapy after TAVI
J. Rodés Cabau
Future perspective and upcoming studies
P. Vranckx